Evidence map›Paper›PMID 20732958›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2010

Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regulation of hepatic and pulmonary mouse CYP1A1 expression and augmented human CYP1A1 transcriptional activation in response to 3-methylcholanthrene in vivo.

Weiwu Jiang, Lihua Wang, Sudha R Kondraganti, Inayat S Fazili, Xanthi I Couroucli, Edward A Felix, Bhagavatula Moorthy

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Repurposing antifungal drugs for cancer therapy.Journal of advanced research · 2023
    Review
  2. Article
  3. The Multifarious Link between Cytochrome P450s and Cancer.Oxidative medicine and cellular longevity · 2020
    Review
  4. Article
  5. Article
  6. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Weiwu JiangBaylor College of Medicine, 1102 Bates Street, Suite 530.01, Houston, TX 77030, USA.
Lihua Wang
Sudha R Kondraganti
Inayat S Fazili
Xanthi I Couroucli
Edward A Felix
Bhagavatula Moorthy
Baylor College of Medicine · US

Funding

MOLECULAR MECHANISMS OF CYTOCHROME P4501A1 EXPRESSIONR01ES009132 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 1998 to 2017
$3.8M
Molecular mechanisms of cytochrome P4501A regulation by hyperoxiaR01HL070921 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2004 to 2010
$2.0M
Roles of pulmonary and hepatic P4501A enzymes in hyperoxic lung injury in miceR01HL087174 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2007 to 2010
$1.5M
NHLBI NIH HHS R01 HL070921NHLBI NIH HHS R01-HL070921NHLBI NIH HHS R01 HL087174NHLBI NIH HHS R01-HL087174NIEHS NIH HHS R01 ES009132NIEHS NIH HHS R01-ES009132
6 · The paper itself

Abstract

The cytochrome P4501A (CYP1A) enzymes play important roles in the metabolic activation and detoxification of numerous environmental carcinogens, including polycyclic aromatic hydrocarbons (PAHs). In this study, we tested the hypothesis that hepatic CYP1A2 differentially regulates mouse hepatic and pulmonary CYP1A1 expression and suppresses transcriptional activation of human CYP1A1 (hCYP1A1) promoter in response to 3-methylcholanthrene (MC) in vivo. Administration of wild-type (WT) (C57BL/6J) or Cyp1a2-null mice with a single dose of MC (100 μmol/kg i.p.) caused significant increases in hepatic CYP1A1/1A2 activities, apoprotein content, and mRNA levels 1 day after carcinogen withdrawal compared with vehicle-treated controls. The induction persisted in the WT, but not Cyp1a2-null, animals, for up to 15 days. In the lung, MC caused persistent CYP1A1 induction for up to 8 days in both genotypes, with Cyp1a2-null mice displaying a greater extent of CYP1A1 expression. It is noteworthy that MC caused significant augmentation of human CYP1A1 promoter activation in transgenic mice expressing the hCYP1A1 and the reporter luciferase gene on a Cyp1a2-null background, compared with transgenic mice on the WT background. In contrast, the mouse endogenous hepatic, but not pulmonary, persistent CYP1A1 expression was repressed by MC in the hCYP1A1-Cyp1a2-null mice. Liquid chromatography-mass spectrometry experiments showed that CYP1A2 catalyzed the formation of 1-hydroxy-3-MC and/or 2-hydroxy-3-MC, a metabolite that may contribute to the regulation of CYP1A1 expression. In conclusion, the results suggest that CYP1A2 plays a pivotal role in the regulation of hepatic and pulmonary CYP1A1 by PAHs, a phenomenon that potentially has important implications for PAH-mediated carcinogenesis.

Indexed as

AnimalsBlotting, WesternCarcinogens, EnvironmentalCytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2Electrophoresis, Polyacrylamide GelFemaleGene Expression Regulation, EnzymologicHumansLiverLungMethylcholanthreneMiceMice, Inbred C57BLMice, KnockoutReverse Transcriptase Polymerase Chain ReactionCarcinogens, EnvironmentalCytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2Methylcholanthrene

Identifiers

PMID20732958
PMCPMC2967398
OpenAlexW2157499457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.